CTSH vs XERS · P/E 12, rev $21.11B vs rev $175.2M
Cognizant Technology Solutions Corp Class A (CTSH) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. XERS currently screens at market cap $760.7M.
Not investment advice. Open the CTSH and XERS stock pages for the full models.
Not investment advice.